The use of bupropion in hospitalized depressed patients.

Author: FeighnerJ P, MeridethC H

Paper Details 
Original Abstract of the Article :
Bupropion and placebo were compared in hospitalized nonpsychotic depressed patients over a 28-day period. It was found that bupropion was significantly more effective than placebo in alleviating depression and that the incidence of adverse effects was similar in bupropion- and placebo-treated patien...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/6406471

データ提供:米国国立医学図書館(NLM)

Bupropion: A New Oasis in the Desert of Depression

Depression, like a vast desert, can be a lonely and isolating experience. This study explores the use of bupropion, an antidepressant, in hospitalized patients suffering from depression. The researchers, like skilled travelers navigating a challenging terrain, investigated the efficacy and safety of bupropion in this patient population. Their aim was to determine if bupropion, like a well-placed oasis, could offer relief from the symptoms of depression.

Finding Relief in the Desert of Depression

The study's findings, like a shimmering oasis in the desert, suggest that bupropion can be an effective treatment for depression. The researchers found that bupropion was significantly more effective than placebo in reducing depressive symptoms. Furthermore, bupropion was well-tolerated, with a similar incidence of side effects compared to placebo. This suggests that bupropion, like a refreshing oasis, can offer a safe and effective treatment option for hospitalized patients with depression.

Navigating the Challenges of Depression Treatment

The desert of depression can be a challenging landscape, demanding a multifaceted approach to treatment. While the study's findings are encouraging, the use of bupropion, like any oasis in the desert, comes with certain considerations. The researchers acknowledged that bupropion may not be suitable for all patients with depression, particularly those with a history of seizures or eating disorders. They also emphasized the importance of careful monitoring for potential side effects. The study's findings highlight the need for personalized treatment strategies and ongoing research to improve our understanding of depression and develop new and effective treatments.

Dr. Camel's Conclusion

This study offers a beacon of hope for those navigating the desert of depression. Bupropion shows promise as a safe and effective treatment option, offering relief from the debilitating symptoms of depression. The research journey continues, but this study is a testament to the ongoing efforts to find effective treatments for this complex and challenging mental health condition.

Date :
  1. Date Completed 1983-07-08
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

6406471

DOI: Digital Object Identifier

6406471

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.